Qualitative Analysis of Proteins in Two Snake Venoms, Gloydius Blomhoffii and Agkistrodon Acutus

키워드

참고문헌 (53)

1. Markland FS, "Snake venoms and the hemostatic system", Toxicon, 36(12), pp.1749~1800 (1998)
2. Fry BG, "Structure-function properties of venom components from Australian elapids", Toxicon, 37(1), pp.11~32 (1999)
3. Williams D, "The global snake bite initiative : an antidote for snake bite", Lancet, 375(9708), pp.89~91 (2010)
4. Kasai K, "Antibacterial properties of L-amino acid oxidase : mechanisms of action and perspectives for therapeutic applications", Appl Microbiol Biotechnol, 99(19), pp.7847~7857 (2015)
5. Chellapandi P, "Structural, functional and therapeutic aspects of snake venom metalloproteinases", Mini Rev Org Chem, 11(1), pp.28~44 (2014)
6. Chong HP, "Cytotoxicity of snake venoms and cytotoxins from two Southeast Asian cobras (Naja sumatrana , Naja kaouthia ): exploration of anticancer potential, selectivity, and cell death mechanism", Front Mol Biosci, 7, pp.583587~ (2020)
7. Dufton MJ, "Conformational properties of the neurotoxins and cytotoxins isolated from Elapid snake venoms", CRC Crit Rev Biochem, 14(2), pp.113~171 (1983)
8. Basus VJ, "NMR solution structure of an alpha-bungarotoxin", nicotinic receptor peptide complex, 1993, pp.32(46), 12290~12298
9. Conti-Tronconi BM, "Alpha-bungarotoxin and the competing antibody WF6 interact with different amino acids within the same cholinergic subsite", Biochemistry, 30(10), pp.2575~2584 (1991)
10. Tzartos SJ, "Fine localization of the major alpha-bungarotoxin binding site to residues alpha 189-195 of the Torpedo acetylcholine receptor. Residues 189, 190, and 195 are indispensable for binding", J Biol Chem, 265(35), pp.21462~21467 (1990)
11. Radding W, "Alpha-toxin binding to acetylcholine receptor alpha 179-191peptides : intrinsic fluorescence studies", FEBS Lett, 231(1), pp.212~216 (1988)
12. Grognet JM, "Circular dichroic spectra of elapid cardiotoxins", Eur J Biochem, 172(2), pp.383~388 (1988)
13. Kini RM, "Mechanism of platelet effects of cardiotoxins from Naja nigricollis crawshawii (spitting cobra) snake venom", Thromb Res, 52(3), pp.185~195 (1988)
14. Hinman C, "Effects of cardiotoxin D from Naja naja siamensis snake venom upon murine splenic lymphocytes", Toxicon, 25(9), pp.1011~1014 (1987)
15. Takechi M, "Binding of cardiotoxin analogue III from Formosan cobra venom to FL cells", FEBS Lett, 205(1), pp.143~146 (1986)
16. Gatineau E, "Delineation of the functional site of a snake venom cardiotoxin : preparation, structure, and function of monoacetylated derivatives", Biochemistry, 29(27), pp.6480~6489 (1990)
17. Igari R, "Binocular diplopia and ptosis due to snakebite (Agkistrodon blomhoffi“mamushi”)--a case report", Brain Nerve, 62(3), pp.273~277 (2010)[DOI]
18. Sakurai Y, "Anticoagulant activity of M-LAO, L-amino acid oxidase purified from Agkistrodon halys blomhoffii, through selective inhibition of factor IX", Biochim Biophys Acta, 1649(1), pp.51~57 (2003)
19. Yamazaki Y, "Cloning and characterization of novel snake venom proteins that block smooth muscle contraction", Eur J Biochem, 269(11), pp.2708~2715 (2002)
20. Sajevic T, "Haemostatically active proteins in snake venoms", Toxicon, 57(5), pp.627~645 (2011)
21. Vaiyapuri S, "Purification and functional characterisation of rhiminopeptidase A, a novel aminopeptidase from the venom of Bitis gabonica rhinoceros", PLoS Negl Trop Dis, 4(8), pp.e796~ (2010)
22. Markland FS Jr, "Snake venom metalloproteinases", Toxicon, 62, pp.3~18 (2013)
23. Fox JW, "Timeline of key events in snake venom metalloproteinase research", J Proteomics, 72(2), pp.200~209 (2009)
24. Fox JW, "Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases", Toxicon, 45(8), pp.969~985 (2005)
25. Gutiérrez J, "Snake venom metalloproteinases : their role in the pathogenesis of local tissue damage", Biochimie, 82(9-10), pp.841~850 (2000)
26. Estêvão-Costa MI, "Action of metalloproteinases mutalysin I and II on several components of the hemostatic and fibrinolytic systems", Thromb Res, 99(4), pp.363~376 (2000)
27. Kamiguti AS, "Proteolytic cleavage of the beta1 subunit of platelet alpha2beta1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72", J Biol Chem, 272(51), pp.32599~32605 (1997)
28. Smith J, "Identification of 50 kDa snake venom proteins which specifically inhibit platelet adhesion to collagen", FEBS Lett, 283(2), pp.307~310 (1991)
29. Sanchez EF, "Chimeric fibrolase : covalent attachment of an RGD-like peptide to create a potentially more effective thrombolytic agent", Thromb Res, 87(3), pp.289~302 (1997)
30. Liu CZ, "Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents plateletcollagen interaction", Arch Biochem Biophys, 337(2), pp.291~299 (1997)
31. Swenson S, "Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation", Arch Biochem Biophys, 384(2), pp.227~237 (2000)
32. Yamazaki Y, "Structure and function of snake venom cysteine-rich secretory proteins", Toxicon, 44(3), pp.227~231 (2004)
33. Yamazaki Y, "Snake venom components affecting blood coagulation and the vascular system : structural similarities and marked diversity", Curr Pharm Des, 13(28), pp.2872~2886 (2007)
34. Sunagar K, "Evolution of CRISPs associated with toxicoferan-reptilian venom and mammalian reproduction", Mol Biol Evol, 29(7), pp.1807~1822 (2012)
35. Matsunaga Y, "Structural divergence of cysteine-rich secretory proteins in snake venoms", J Biochem, 145(3), pp.365~375 (2009)
36. Brown RL, "Pseudechetoxin : a peptide blocker of cyclic nucleotide-gated ion channels", Proc Natl Acad Sci U S A, 96(2), pp.754~759 (1999)
37. Tasoulis T, "A review and database of snake venom proteomes", Toxins (Basel), 9(9), pp.290~ (2017)
38. Koh DC, "Snake venom components and their applications in biomedicine", Cell Mol Life Sci, 63(24), pp.3030~3041 (2006)
39. Kini RM, "Excitement ahead : structure, function and mechanism of snake venom phospholipase A2 enzymes", Toxicon, 42(8), pp.827~840 (2003)
40. Gutiérrez JM, "Phospholipases A2 : unveiling the secrets of a functionally versatile group of snake venom toxins", Toxicon, 62, pp.27~39 (2013)
41. Cummings BS, "Phospholipase A2 as targets for anti-cancer drugs", Biochem Pharmacol, 74(7), pp.949~959 (2007)
42. Mashima T, "De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy", Br J Cancer, 100(9), pp.1369~1372 (2009)
43. Ferguson EL, "Studies on the mechanism of action of dextrin-phospholipase A2 and its suitability for use in combination therapy", Mol Pharm, 7(2), pp.510~521 (2010)
44. Roberto PG, "Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom", Protein J, 23(4), pp.273~285 (2004)
45. Araya C, "Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms", Cell Biol Int, 31(3), pp.263~268 (2007)
46. Maity G, "Purification and characterization of a low molecular weight multifunctional cytotoxic phospholipase A2 from Russell’s viper venom", J Chromatogr B Analyt Technol Biomed Life Sci, 845(2), pp.232~243 (2007)
47. Khunsap S, "Purification of a phospholipase A(2) from Daboia russelii siamensis venom with anticancer effects", J Venom Res, 2, pp.42~51 (2011)
48. Rodrigues RS, "Structural and functional properties of Bp-LAAO, a new L-amino acid oxidase isolated from Bothrops pauloensis snake venom", Biochimie, 91(4), pp.490~501 (2009)
49. Kessentini-Zouari R, "CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venom-derived phospholipases A2, inhibit angiogenesis both in vitro and in vivo", Lab Invest, 90(4), pp.510~519 (2010)
50. Morita T, "Structures and functions of snake venom CLPs(C-type lectin-like proteins)with anticoagulant-, procoagulant-, and platelet-modulating activities", Toxicon, 45(8), pp.1099~1114 (2005)
51. Clemetson KJ, "Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors", Toxicon, 56(7), pp.1236~1246 (2010)
52. Calderon LA, "Antitumoral activity of snake venom proteins : new trends in cancer therapy", Biomed Res Int, 2014, pp.203639~ (2014)
53. Kunalan S, "Proteomic characterization of two medically important Malaysian snake venoms, Calloselasma rhodostoma (Malayan Pit Viper) and Ophiophagus hannah (King Cobra)", Toxins (Basel), 10(11), pp.434~ (2018)

관련 논문AI추천